In vivo monitoring of intranuclear p27(kip1) protein expression in breast cancer cells during trastuzumab (Herceptin) therapy.

INTRODUCTION: Trastuzumab, a humanized antibody directed against the Her2 receptor, induces the expression of p27(kip1), an intranuclear cyclin-dependent kinase inhibitor in some breast cancer cells. The aim of this study was to develop a radioimmunoconjugate (RIC) to monitor trastuzumab-induced p27...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Cornelissen, B, Kersemans, V, McLarty, K, Tran, L, Vallis, K, Reilly, R
التنسيق: Journal article
اللغة:English
منشور في: 2009